Nagpur
+919405117673
+919405117673

Pazinib (Pazopanib) 200mg & 400mg Tablets: Effective Targeted Therapy for Kidney Cancer

Cancer treatment has evolved significantly with the introduction of targeted therapies. Pazinib (Pazopanib) 200mg and 400mg Tablets by Cordium Pharmaceuticals Pvt Ltd offer an advanced treatment option for patients diagnosed with advanced renal cell carcinoma (kidney cancer) and advanced soft tissue sarcoma. As a trusted Indian pharmaceutical exporter, Cordium Pharmaceuticals supplies high-quality oncology medicines worldwide, ensuring accessibility, affordability, and global healthcare support. What is Pazinib (Pazopanib)? Pazinib contains Pazopanib, an oral tyrosine kinase inhibitor (TKI) that blocks proteins responsible for tumor growth and blood vessel formation. It works by inhibiting: VEGFR (Vascular Endothelial Growth Factor Receptors) PDGFR (Platelet-Derived Growth Factor Receptors) c-Kit receptors By blocking these pathways, Pazopanib slows cancer progression and reduces tumor growth. Medical Uses of Pazinib (Pazopanib) 1. Advanced Renal Cell Carcinoma (RCC) Pazinib is prescribed for adults with advanced kidney cancer to help delay disease progression. 2. Advanced Soft Tissue Sarcoma (STS) Used in adults who have previously received chemotherapy for advanced soft tissue sarcoma. Always use under the supervision of a qualified oncologist. Available Strengths Pazinib 200mg Tablets Ideal for dose adjustments and individualized treatment plans. Pazinib 400mg Tablets Commonly prescribed for standard therapeutic dosing. Available packaging options can be customized for international markets. Key Benefits of Pazinib (Pazopanib) ✅ Targeted cancer therapy ✅ Oral administration (no hospital infusion required) ✅ Helps delay tumor progression ✅ Convenient once-daily dosing ✅ International quality standards ✅ Affordable alternative for global markets Recommended Dosage The typical adult dose is: 800 mg orally once daily Important instructions: Take on an empty stomach. Consume at least 1 hour before or 2 hours after meals. Swallow tablets whole. Do not crush, split, or chew tablets. Follow physician instructions carefully. Dosage may vary depending on: Liver function Drug interactions Patient tolerance Oncologist recommendations Possible Side Effects Common side effects include: High blood pressure Diarrhea Fatigue Nausea Loss of appetite Hair color changes Weight loss Elevated liver enzymes Headache Seek immediate medical attention if severe symptoms occur. Precautions Before Using Pazinib Inform your doctor if you have: Liver disease Heart conditions High blood pressure Bleeding disorders Thyroid disorders Recent surgery Pregnancy or breastfeeding concerns Regular monitoring may include: Liver function tests Blood pressure checks ECG monitoring Thyroid function tests Why Choose Cordium Pharmaceuticals Pvt Ltd? Cordium Pharmaceuticals Pvt Ltd is committed to delivering high-quality, affordable oncology medicines worldwide. Our Strengths: ✔ WHO-GMP compliant manufacturing partners ✔ International export capabilities ✔ Competitive pricing ✔ Reliable supply chain ✔ Custom documentation support ✔ Bulk supply for distributors and hospitals ✔ Regulatory assistance for global markets Countries We Export To Cordium Pharmaceuticals proudly supplies oncology medicines to: 🇰🇪 Kenya 🇳🇬 Nigeria 🇬🇭 Ghana 🇵🇭 Philippines 🇻🇳 Vietnam 🇦🇪 UAE 🇸🇦 Saudi Arabia 🇺🇿 Kazakhstan 🇰🇿 Uzbekistan 🇺🇸 USA 🇬🇧 UK 🇿🇦 South Africa We support: Pharmaceutical importers Oncology distributors Government tenders Hospitals Cancer treatment centers Wholesalers Frequently Asked Questions (FAQs) Is Pazinib (Pazopanib) chemotherapy? No. Pazinib is a targeted therapy medicine and not conventional chemotherapy. Can Pazinib cure cancer? Pazinib helps control disease progression but is not considered a cure. Can patients take Pazinib at home? Yes. It is an oral tablet prescribed for home administration under oncologist supervision. Is Pazinib available internationally? Yes. Cordium Pharmaceuticals supports global exports to multiple countries.
 2026-06-20T13:57:12

Keywords